InVivo Therapeutics Corp organizacji Current ratio
Jaka jest wartość Current ratio organizacji InVivo Therapeutics Corp?
Wartość Current ratio organizacji InVivo Therapeutics Holdings Corp to 14.30
Jaka jest definicja Current ratio?
Wskaźnik bieżącej płynności to wskaźnik płynności, który określa, czy firma ma wystarczające zasoby, aby wywiązać się z zobowiązań krótkoterminowych.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio firm w Health Care sektor na NASDAQ w porównaniu do InVivo Therapeutics Corp
Czym się zajmuję organizacja InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Firmy z current ratio podobne do InVivo Therapeutics Corp
- Wartość Current ratio organizacji Rex Resources Corp to 14.19
- Wartość Current ratio organizacji Amcil to 14.21
- Wartość Current ratio organizacji Source Rock Royalties Ltd to 14.22
- Wartość Current ratio organizacji Flying Nickel Mining to 14.24
- Wartość Current ratio organizacji China Rare Earth to 14.28
- Wartość Current ratio organizacji Advanced Blockchain AG to 14.29
- Wartość Current ratio organizacji InVivo Therapeutics Corp to 14.30
- Wartość Current ratio organizacji MaxCyte to 14.30
- Wartość Current ratio organizacji MFF Capital Investments to 14.32
- Wartość Current ratio organizacji DLC Asia to 14.32
- Wartość Current ratio organizacji Greencoat UK Wind Plc to 14.34
- Wartość Current ratio organizacji Genesis Acquisition to 14.34
- Wartość Current ratio organizacji Atossa Therapeutics Inc to 14.35